What is propelling the biopsy devices industry?
Grand View Research, Inc
Market Research Technology | Management Consulting | Analytics
As healthcare systems evolve, biopsy devices have become essential tools in the diagnosis and treatment of various conditions, particularly cancer. According to the WHO, cancer is a major contributor to global mortality. It causes about 1 in every 6 deaths and affects nearly every household. There were an estimated 20 million new cases of cancer and around 10 million deaths from cancer worldwide in 2022. The rising cases of cancer result in a higher demand for biopsy devices.?
Biopsy devices are instruments used to extract tissue samples for diagnostic examinations. These tools range from traditional methods, such as needle biopsies, to advanced technologies like endoscopic biopsies and robotic-assisted systems. Furthermore, the biopsy devices market is evolving rapidly to cope with the rising need for them.??
This blog lays emphasis on the factors propelling the biopsy industry.
Rising Incidence of Cancer: Major Factor Affecting The Industry
The global increase in cancer cases is the most significant driver of the biopsy devices industry. As mentioned above, cancer is one of the leading causes of death worldwide, and early diagnosis through biopsy is crucial for effective treatment of the disease. Rising consumption of tobacco, alcohol, and obesity are the major reasons behind the rise in cancer cases globally. Additionally, growing air pollution is a key risk factor in the increase in cancer cases.?
The Union for International Cancer Control (UICC) predicts 35 million new cancer cases by the year 2050. This will be a 77% increase from 20 million cases in 2022. Moreover, cancer mortality is also projected to almost double by 2050 in low and medium-HDI countries.??
Biopsy Devices Industry: Other Factors Impacting The Growth
Here are some other factors that are anticipated to affect the biopsy devices industry:
Technological advancement is among other significant factors that propel the market. For example, innovations in biopsy devices, including the development of minimally invasive techniques and image-guided biopsies, have enhanced accuracy and reduced recovery times. Technologies such as ultrasound, CT scans, and MRI-guided biopsies have made it easier to target lesions accurately, leading to improved patient outcomes. In May 2023, Argon Medical Devices launched the semi-automatic biopsy instrument “SuperCore Advantage” as the latest addition to its soft tissue biopsy product portfolio. The device is a next generation soft tissue disposable biopsy instrument that provides a superior volume of tissue samples.?
Moreover, patients and healthcare professionals are increasingly preferring minimally invasive procedures. These procedures offer benefits such as reduced pain, shorter hospital stays, and quicker recovery times, which is driving the adoption of advanced biopsy devices that align with these preferences.
Governments and private organizations are investing heavily in cancer research, leading to the development of new biopsy technologies. This investment fosters innovation and creates new market opportunities, enhancing the efficiency of biopsy procedures. For instance, in August 2024, Accenture Ventures announced an investment in Earli Inc., a biotech company known for creating a synthetic biopsy to detect early signs of cancer. Through Earli’s technology, cancerous cells are reprogrammed to reveal and destroy themselves. ??
Furthermore, enhanced healthcare infrastructure, particularly in emerging economies, facilitates better access to advanced diagnostic tools, including biopsy devices. As healthcare systems expand and improve, the demand for effective diagnostic solutions will likely rise.
Beyond oncology, biopsy devices also find applications in various fields, including dermatology, gastroenterology, and cardiology. The expansion of diagnostic capabilities in these areas is driving demand for a broader range of biopsy devices. For example, a catheter-type instrument, a bioptome, is used to perform heart biopsy. Similarly, a biopsy punch is used in dermatology to perform skin biopsies. It is a disposable tool with a round stainless-steel blade that removes the skin sample.
Product Outlook
Needle-based biopsy guns lead the market among the various types of biopsy devices. This segment held the largest market share of 43.1% in 2023. Needle-based biopsy guns collect samples from soft tissues of internal organs. They use a spring-loaded mechanism to extract tissue samples. Semi-automatic biopsy guns are also available.
The demand for biopsy needles will grow significantly over the coming years. These needles are used to access difficult anatomy while performing biopsies. In addition, needle biopsies are accurate, painless, and less invasive than surgical biopsies. Patients generally resume their normal activities soon after needle biopsy.
Future Outlook
As the healthcare industry continues to evolve, ongoing research and development are expected to play a crucial role in shaping the future of biopsy technologies. Innovation has improved these devices' capabilities and accuracy, ultimately leading to better patient outcomes and a more efficient healthcare system. Although these devices are used mainly to diagnose different types of cancer, their wide application has opened new opportunities for manufacturers.
Other Related Reports: